Rahul Dev Jayant, PhD <\/p>\n
Rahul Dev Jayant, assistant professor in the Department of Immunology, has received a $25,000 grant from The Campbell Foundation in Ft. Lauderdale to continue his research on sustained-release nanoformulation to deliver antiretroviral (ARV) medication for patients living with HIV\/AIDS. <\/p>\n
Using FIU patented nanotechnology, Jayant, a researcher at the Herbert Wertheim College of Medicines Center for Personalized Nanomedicine, has successfully integrated Tenofovir, an antiretroviral drug used to fight HIV, into a long-active nanoformulation thatcan release the medication for up to one week. <\/p>\n
Now, with the generous help from The Campbell Foundation, we will be working toward the development of single-dose formulation that can release the ARV drugs up to one month, Jayant said. <\/p>\n<\/p>\n
Bill Venuti and Ken Rapkin (first and third from right) of The Campbell Foundation present the $25K check to the Immunology Department team. <\/p>\n
Sustained release of antiretroviral medication has the potential to be a game changer for many people living with HIV\/AIDS who may have trouble adhering to the daily pill dosing that current treatments require. <\/p>\n
The Campbell Foundation has been funding cutting-edge research into a cure for HIV since its creation in 1995 by the late Richard Campbell Zahn, the chemist who developed Herpecin-L Lip Balm for the treatment of cold sores and fever blisters. <\/p>\n
These fast-track grants to South Florida-based researchers show our Board of Directors ongoing commitment to addressing HIV\/AIDS right here in our own backyard, said Campbell Foundation Trustee Bill Venuti. <\/p>\n
If you're new here, you may want to subscribe to our newsletter. Thanks for visiting! <\/p>\n
<\/p>\n
Here is the original post: <\/p>\n
Researcher awarded grant for HIV\/AIDS drug study - FIU News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Rahul Dev Jayant, PhD Rahul Dev Jayant, assistant professor in the Department of Immunology, has received a $25,000 grant from The Campbell Foundation in Ft. Lauderdale to continue his research on sustained-release nanoformulation to deliver antiretroviral (ARV) medication for patients living with HIV\/AIDS. Using FIU patented nanotechnology, Jayant, a researcher at the Herbert Wertheim College of Medicines Center for Personalized Nanomedicine, has successfully integrated Tenofovir, an antiretroviral drug used to fight HIV, into a long-active nanoformulation thatcan release the medication for up to one week. Continue reading